Stock listing
GTG Stock Price, News, Filings & Events — Genetic Technologies Limited
Selected listing: GTG · ASX · AUD · AU
This page tracks Genetic Technologies Limited's GTG:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GTG:ASX. GTG:ASX is the stock-level entry point for investors researching Genetic Technologies Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genetic Technologies Limited (GTG) is a publicly traded company based in Australia, focusing on genetic testing and related technologies. With a market capitalization of approximately AUD 3.95 million, GTG is engaged in developing innovative solutions in the field of genetics. The company aims to enhance healthcare outcomes through its advanced genetic testing services.

- Ticker
- GTG:ASX
- Asset type
- Stock
- Market cap
- $4.0M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- ASX
- Currency
- AUD
Genetic Technologies Limited GTG:ASX stock context
This page tracks Genetic Technologies Limited's GTG:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GTG:ASX. GTG:ASX is the stock-level entry point for investors researching Genetic Technologies Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genetic Technologies Limited (GTG) is a publicly traded company based in Australia, focusing on genetic testing and related technologies. With a market capitalization of approximately AUD 3.95 million, GTG is engaged in developing innovative solutions in the field of genetics. The company aims to enhance healthcare outcomes through its advanced genetic testing services.
Latest news from Genetic Technologies Limited
Suspension from Official Quotation - Annual Listing Fees
August 23, 2026
Quarterly Activities/Appendix 4C Cash Flow Report June 2025
March 30, 2026
Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025
March 30, 2026
Quarterly Activities/Appendix 4C Cash Flow Report March 2025
March 30, 2026
Update on Proposed Acquisition Strategy
March 24, 2026
Research Genetic Technologies Limited
Genetic Technologies Limited investor report
Review AI stock analysis and investor report context for GTG:ASX.
Genetic Technologies Limited company profile
View the public company page for Genetic Technologies Limited on 6ix.
Genetic Technologies Limited news
Read company news and market updates connected to Genetic Technologies Limited.
Genetic Technologies Limited investor events
Find investor webinars, events, and replay context for Genetic Technologies Limited.
Alternate listings
893882:LSX
DE · EUR
Alternate listing for Genetic Technologies Limited; the primary context on this page is GTG:ASX.
GNTLF:OTC
US · USD
Alternate listing for Genetic Technologies Limited; the primary context on this page is GTG:ASX.
893882:LS
DE · EUR
Alternate listing for Genetic Technologies Limited; the primary context on this page is GTG:ASX.
DU8:FWB
DE · EUR
Alternate listing for Genetic Technologies Limited; the primary context on this page is GTG:ASX.
DU8:SWB
DE · EUR
Alternate listing for Genetic Technologies Limited; the primary context on this page is GTG:ASX.